[Diagnosis and treatment of intravascular coagulation processes].
D000074:Acenocoumarol / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000614:Aminocaproates / Q000627:therapeutic use; D000707:Anaphylaxis / Q000150:complications; D000818:Animals; D001772:Blood Cell Count; D001778:Blood Coagulation Disorders / Q000175:diagnosis / Q000188:drug therapy; D001779:Blood Coagulation Factors; D001780:Blood Coagulation Tests; D001792:Blood Platelets / Q000201:enzymology; D002318:Cardiovascular Diseases / Q000150:complications; D002648:Child; D003937:Diagnosis, Differential; D004285:Dogs; D005260:Female; D005340:Fibrinogen / Q000627:therapeutic use*; D005341:Fibrinolysin / Q000037:antagonists & inhibitors; D005342:Fibrinolysis; D006400:Hematocrit; D006474:Hemorrhagic Disorders / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D006493:Heparin / Q000627:therapeutic use*; D006494:Heparin Antagonists; D006801:Humans; D007938:Leukemia / Q000150:complications; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications; D011247:Pregnancy; D011248:Pregnancy Complications; D011817:Rabbits
D000614:Aminocaproates; D001779:Blood Coagulation Factors; D006494:Heparin Antagonists; D005340:Fibrinogen; D006493:Heparin; D005341:Fibrinolysin; D000074:Acenocoumarol
Diagnostic et traitement des processus de coagulation intravasculaire.